Rise in testing and diagnosis associated with Scotland's Action Plan on hepatitis C and introduction of dried blood spot testing

Journal of Epidemiology and Community Health

Volumn 68, Issue 12, 2014, Pages 1182-1188

  McLeod, Allan ^a   Weir, Amanda ^a,b   Aitken, Celia ^c   Gunson, Rory ^c   Templeton, Kate ^d   Molyneaux, Pamela ^e   McIntyre, Paul ^f   McDonald, Scott ^a,b   Goldberg, David ^a   Hutchinson, Sharon ^a,b  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^c West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

^d Scottish HPV Reference Laboratory   (United Kingdom)

^e ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DATA SET; EPIDEMIC; HEALTH RISK; HEPATITIS; REGRESSION ANALYSIS; RISK FACTOR; VIRAL DISEASE;

SCOTLAND; UNITED KINGDOM;

HEPATITIS C VIRUS;

ADULT; DRIED BLOOD SPOT TESTING; EVALUATION STUDY; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NATIONAL HEALTH SERVICE; REGRESSION ANALYSIS; RISK FACTOR; UNITED KINGDOM; YOUNG ADULT;

ADULT; DRIED BLOOD SPOT TESTING; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SCOTLAND; STATE MEDICINE; YOUNG ADULT;

EID: 84911123627     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2014-204451     Document Type: Article

References (31)

1. Hepatitis C in the UK 2014. London: Health Protection Agency Centre for Infections, 2014. https://www.gov.uk/government/uploads/system/uploads/.
2. Scottish needs assessment programme. Hepatitis C. Glasgow: Office for Public Health in Scotland, 2000.
3. Proceedings of the Consensus Conference on Hepatitis C. April 21-22 2004. Edinburgh, UK. J Viral Hepat 2004;11(Suppl 1):1-39.
4. Scottish Intercollegiate Guidelines Network (SIGN). Management of hepatitis C. Guideline No. 92. December 2006. ISBN 9781905813025.
5. Scottish Government. Hepatitis C Action Plan for Scotland: Phase I (September 2006-April 2008). Edinburgh: Scottish Government, 2006. http://www.scotland. gov.uk/Publications/2006/09/15093626/0
6. Scottish Government. Hepatitis C Action Plan for Scotland: Phase II (May 2008- March 2011). Edinburgh: Scottish Government, 2008. http://www.scotland.gov.uk/ Publications/2008/05/13103055/0
7. Judd A, Parry J, Hickman H, et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003;71:49-55.
8. Bennett S, Gunson RN, McAllister GE, et al. Detection of hepatitis C virus RNA in dried blood spots. J Clin Virol 2012;54:106-9.
9. McLeod A, Hutchison S, Goldberg D. Surveillance of known hepatitis C antibody positive cases in Scotland: results to 31 December 2012. HPS Weekly Report 2013;47:151-4.
10. Cummins C, Winter H, Cheng KK, et al. An assessment of the Nam Pehchan computer program for the identification of names of south Asian ethnic origin. J Public Health Med 1999;21:401-6.
11. England K, Pembrey L, Tovo PA, et al. European Paediatric HCV Network. Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers. Acta Paediatr 2005;94:444-50. Erratum in: Acta Paediatr 200594:814.
12. Wagner AK, Soumerai SB, Zhang F, et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299-309.
13. Ver Hoef JM, Boveng PL. Quasi-Poisson vs. negative binomial regression: how should we model overdispersed count data? Ecology 2007;88:2766-72.
14. McDonald SA, Hutchinson SJ, Schnier C, et al. Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture-recapture methods. Epidemiol Infect 2014;142:200-7.
15. The Negative Impact of the War on Drugs on Public Health: The Hidden Hepatitis C Epidemic. Global Commission on Drug Policy. May 2013.
16. Cornberg M, Razavi HA, Alberti A, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011;31(Suppl 2):30-60.
17. Hickman M, McDonald T, Judd A, et al. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial. J Viral Hepat 2008;15:250-4.
18. Craine N, Parry J, O'Toole J, et al. Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service. J Viral Hepat 2009;16:219-22.
19. Hope VD, Hickman M, Ngui SL, et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat 2011;18:262-70.
20. Martin NK, Hickman M, Miners A, et al. Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons. BMJ Open 2013;3. pii: e003153.
21. McDonald SA, Hutchinson SJ, Innes HA, et al. Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan. J Viral Hepat 2014;21:366-76.
22. Datta S, Horwood J, Hickman M, et al. Case-finding for hepatitis C in primary care: a mixed-methods service evaluation. Br J Gen Pract 2014;64:e67-74.
23. Cullen BL, Hutchinson SJ, Cameron SO, et al. Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention. J Public Health (Oxf) 2012;34:14-23.
24. Anderson EM, Mandeville RP, Hutchinson SJ, et al. Evaluation of a general practice based hepatitis C virus screening intervention. Scott Med J 2009;5:3-7.
25. National Institute for Health and Care Excellence. Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection. PH43. London: National Institute for Health and Care Excellence, 2012.
26. CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998;47:1-39.
27. Smith BD, Morgan RL, Beckett GA, et al. Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012;61:1-32.
28. Information Services Division. Drug Misuse Statistics Scotland 2011. Edinburgh, 2012.
29. Langley T, Szatkowski L, Lewis S, et al. The freeze on mass media campaigns in England: a natural experiment of the impact of tobacco control campaigns on quitting behaviour. Addiction 2014;109:995-1002.
30. Lopez Bernal JA, Gasparrini A, Artundo CM, et al. The effect of the late 2000s financial crisis on suicides in Spain: an interrupted time-series analysis. Eur J Public Health 2013;23:732-6.
31. Bastuji-Garin S, Sbidian E, Gaudy-Marqueste C, et al. European Dermatology Network (EDEN). Impact of STROBE statement publication on quality of observational study reporting: interrupted time series versus before-after analysis. PLoS ONE 2013;8:e64733.